Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?
Crossref DOI link: https://doi.org/10.1007/s00520-015-2805-7
Published Online: 2015-06-17
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Skedgel, Chris http://orcid.org/0000-0003-4989-8846
Rayson, Daniel
Younis, Tallal
Text and Data Mining valid from 2015-06-17